Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ViroPharma Biologics LLC v. CSL Behring LLC et al
Case Number:
1:17-cv-00414
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 19, 2020
COVID-19 IP Catch-Up: Trials Get Delayed, Moved To Video
As the COVID-19 pandemic wages on, more trials are being pushed into August and beyond, and others are gearing up for remote proceedings. Here are some recent intellectual property updates tied to the outbreak that you may have missed.
-
June 17, 2020
Shire Wants Jury Trial Over Validity Of Its Genetic Disorder IP
Shire ViroPharma Inc. said Wednesday that it wants to seek a federal jury trial in Delaware on the validity of its patents for a genetic disorder treatment in a dispute with CSL Behring LLC, despite the difficulties posed by the COVID-19 pandemic and ongoing court activity restrictions.
-
January 08, 2018
CSL Must Face Shire's Willful Infringement Claim
CSL Behring LLC launched its genetic disorder treatment Haegarda despite knowing it could infringe one of Shire ViroPharma Inc.'s patents, so it must face claims that it willfully infringed that patent, a Delaware federal judge said Monday.
-
April 19, 2017
Shire Files Infringement Suit On Same Day It Gets Drug Patent
Shire ViroPharma Inc. has sued CSL Behring LLC in Delaware federal court, alleging on the same day Shire received patent protection for a genetic disorder treatment that CSL’s upcoming drug to treat the same condition will infringe its new patent.